4th Quarter - Report
THE NICKLES GROUP, LLC for EMERGENT BIOSOLUTIONS
Client
Income
$37,500
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY 2019 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Defense DEF
NDAA - provisions related to biological and chemical defense.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DONALD KENT | — |
Health Issues HCR
Re-authorization of the Pandemic and All-Hazards Preparedness Act. Opioid and heroin addiction legislation, Naloxone access, coprescribing/opioid prescribing guideline.
| Lobbyist | Covered position, as disclosed |
|---|---|
| STACEY HUGHES New | U.S. Senate Budget Cmte, Dpty Staff Dir;Ofce of the Asst. Maj. Ldr (Sen. Nickles), Policy Adv; Office of the Asst. Min. Ldr (Sen. Nickles), Policy Adv.;Senate Spec. Cmte on Aging (Sen.Cohen),Prof. Staff Member; U.S.Sen Connie Mack, Leg Asst/Schdlr |
| DONALD KENT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.